Diabetes, cancer still top areas for innovation: U.S. pharmaceuticals patent landscape report
Our analysis of the U.S. pharmaceutical patent landscape in 2023 reveals that diseases like diabetes, respiratory conditions, and cancer remain at the forefront innovation. These